butabarbital will minimize the level or effect of doravirine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. These agents must only be merged if alternative treatment method solutions are inadequate. If mixed, limit the dosages and length of every drug. Consider therapy